Scientists test First-of-its-Kind vaccine to stop malaria spread
NCT ID NCT05913973
Summary
This study tested a new vaccine designed to stop the spread of malaria by mosquitoes, not to protect the person getting the shot. Researchers gave the vaccine to 105 healthy adults who had never had malaria to check if it was safe and if it triggered an immune response. Volunteers received three shots over two months and were followed for over a year to monitor their health.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.